Clinical Study on Treatment of Severe Acute Pancreatitis by Integrative Chinese and Western Medicine Combined with Somatostatin  

作　　者：夏庆 袁琳 杨晓楠 蒋俊明 

机构地区：[1]Department of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University

出　　处：《Chinese Journal of Integrated Traditional and Western Medicine》2003年第4期305-305,共1页中国中西医结合杂志（英文版）

摘　　要：Objective: To study whether the therapeutic effect could be enhanced by combined use of somatostatin and conventional integrative Chinese and western medicine (TCM-WM) in treating severe acute pancreatitis (SAP). Methods: Sixty patients of SAP were randomly divided equally into the somatostatin group (Group A) and the basis treated group , they were all treated with non-surgical TCM-WM treatment, but to Group A, the intravenous injection of somatostatin 250 μg/h for 72 hrs continuously was given additionally. Laboratory parameters, condition of disease and therapeutic effect indexes, including occurrence of organic dysfunction, local complication and mortality, between the two groups were compared. Results: The recovery of serum levels of amylase, lipase, C reaction protein, lactate dehydrogenase, aspartate aminotransferase, as well as the scores of APACHE Ⅱ in Group A were quicker than those in Group B (P<0 05). The occurrence of organic dysfunction and local com plication in Group A were lower to those in Group B, but without statistic significance. Comparison of the mortality in the two groups showed insignificant difference ( P> 0 05). Conclusion: The early stage short course of combined TCM-WM and somatostatin treatment could improve the condition of SAP, but its effect on mortality should be further verified by enlarging the sample size.Objective: To study whether the therapeutic effect could be enhanced by combined use of somatostatin and conventional integrative Chinese and western medicine (TCM-WM) in treating severe acute pancreatitis (SAP). Methods: Sixty patients of SAP were randomly divided equally into the somatostatin group (Group A) and the basis treated group , they were all treated with non-surgical TCM-WM treatment, but to Group A, the intravenous injection of somatostatin 250 μg/h for 72 hrs continuously was given additionally. Laboratory parameters, condition of disease and therapeutic effect indexes, including occurrence of organic dysfunction, local complication and mortality, between the two groups were compared. Results: The recovery of serum levels of amylase, lipase, C reaction protein, lactate dehydrogenase, aspartate aminotransferase, as well as the scores of APACHE Ⅱ in Group A were quicker than those in Group B (P<0 05). The occurrence of organic dysfunction and local com plication in Group A were lower to those in Group B, but without statistic significance. Comparison of the mortality in the two groups showed insignificant difference ( P> 0 05). Conclusion: The early stage short course of combined TCM-WM and somatostatin treatment could improve the condition of SAP, but its effect on mortality should be further verified by enlarging the sample size.

关 键 词：SARS 中西医结合 重症急性呼吸道综合征 临床疗效 C反应蛋白 

分 类 号：R576[医药卫生—消化系统]